For citations:

Susekov A.V., Bulatov V.A., Vigdorchik A.V. QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY. Rational Pharmacotherapy in Cardiology. 2010;6(4):447-454. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-4-447-454